Novel and Investigational Treatments for Onychomycosis
Onychomycosis is a common nail disease caused by fungi. The primary pathogens are dermatophytes; however, yeasts, non-dermatophyte moulds, and mixed fungal populations may also contribute to the development of a recalcitrant condition, usually accompanied by difficulties in everyday life and severe...
Main Authors: | Stamatios Gregoriou, Maria Kyriazopoulou, Aikaterini Tsiogka, Dimitrios Rigopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-10-01
|
Series: | Journal of Fungi |
Subjects: | |
Online Access: | https://www.mdpi.com/2309-608X/8/10/1079 |
Similar Items
-
Preparation and in vivo evaluation of a highly skin- and nail-permeable efinaconazole topical formulation for enhanced treatment of onychomycosis
by: Byung Chul Lee, et al.
Published: (2019-01-01) -
Extended Use of Topical Efinaconazole Remains Safe and Can Provide Continuing Benefits for Dermatophyte Toenail Onychomycosis
by: Aditya K. Gupta, et al.
Published: (2024-08-01) -
Transungual Penetration and Antifungal Activity of Prescription and Over-the-Counter Topical Antifungals: Ex Vivo Comparison
by: Ali Elabbasi, et al.
Published: (2024-08-01) -
Design, Development, and Evaluation of Constant Voltage Iontophoresis for the Transungual Delivery of Efinaconazole
by: Anroop B. Nair, et al.
Published: (2023-05-01) -
Safety and Efficacy of a 48-Month Efinaconazole 10% Solution Treatment/Maintenance Regimen: 24-Month Daily Use Followed by 24-Month Intermittent Use
by: Aditya K. Gupta, et al.
Published: (2025-01-01)